Mild cognitive impairment (MCI) is a condition characterized by cognitive decline that is greater than would be expected for an individual's age, but not severe enough to interfere significantly with daily life activities. It is considered a transitional stage between normal age-related cognitive changes and more serious forms of cognitive impairment, such as Alzheimer's disease. Individuals with MCI may experience problems with memory, language, executive function, or other cognitive abilities. However, these deficits do not typically interfere with overall cognitive function or independence in daily activities. Research in the area of MCI aims to better understand the causes, progression, and potential interventions for this condition. This may include studying biomarkers for early detection, cognitive training programs, lifestyle interventions, and pharmacological treatments to potentially prevent or slow down the progression to more severe forms of cognitive impairment. Overall, research in the area of MCI is important for improving detection, early intervention, and ultimately, the quality of life for individuals at risk for developing dementia.